Raymond James Financial Services Advisors’s Medicines Co MDCO Stock Holding History

Raymond James Financial Services Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,528	Closed	-$300K	–	2975
2019 Q4	$300K	Buy	+3,528	New	+$235K	﹤0.01%	2326

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Raymond James Financial Services Advisors's MDCO Position: Q1 2020 in Review

Raymond James Financial Services Advisors sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 3,528 shares — an estimated $300K sold.

Raymond James Financial Services Advisors first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $300K in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Raymond James Financial Services Advisors reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Raymond James Financial Services Advisors sold 3,528 Medicines Co shares in Q1 2020, an estimated $300K.
Raymond James Financial Services Advisors first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Raymond James Financial Services Advisors's Medicines Co position peaked at $300K in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q1 2020, filed 21 Apr 2020.